OVID THERAPEUTICS INC.

Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026

18 10 2023 08:00:01 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit

10 10 2023 08:00:01 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023

26 9 2023 07:30:00 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference

20 9 2023 07:30:00 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Participate in Upcoming September Investor Conferences

30 8 2023 08:00:00 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Updates

04 8 2023 08:00:00 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the BTIG Virtual Biotechnology Conference 2023

01 8 2023 08:00:01 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy Officer

28 6 2023 08:00:01 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Added to Russell 3000® Index

26 6 2023 08:00:00 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Reports First Quarter 2023 Financial Results and Corporate Updates

05 5 2023 07:30:00 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Announces Collaboration with Graviton Bioscience, Proven Developers of Selective ROCK2 Inhibitors

01 5 2023 06:00:00 提供 Nasdaq GlobeNewswire

Long-term Safety & Efficacy Findings from Soticlestat Open Label Extension Study Presented by Takeda at American Academy of Neurology Annual Meeting

27 4 2023 14:30:14 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference

10 4 2023 08:00:00 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2022 Financial Results

13 3 2023 08:00:01 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the 2nd Annual Needham Virtual Neuroscience Forum

09 3 2023 08:00:01 提供 Nasdaq GlobeNewswire

Studies Published in Cell Reports Medicine Validate the Potential of Direct KCC2 Activation in Resistant Seizures

08 3 2023 08:00:00 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the 43rd Annual Cowen Healthcare Conference

28 2 2023 08:00:02 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Expands Epilepsy Development Expertise with New Appointments

08 2 2023 08:00:01 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Dosed Healthy Volunteers with OV329 in Phase 1 Trial

05 1 2023 08:00:45 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Present Data on Its Epilepsy Programs at American Epilepsy Society Annual Meeting (2022)

02 12 2022 10:00:00 提供 Nasdaq GlobeNewswire